08Jun
FDA Signals a Deliberative Approach to Cannabis at Public Hearing
While it was ostensibly convened to gather scientific input from stakeholders on how to appropriately regulate cannabis-infused products, the Food and Drug Administration (FDA) also used the May 31, 2019 public hearing as a platform to issue a call...
By:
Wilson Sonsini Goodrich & Rosati
Related
California is potentially setting the precedent on how “employees” will be defined in the future. ...
Read More >
Private equity firm Oak Hill Capital Partners owned ODN Holding Corporation, a holding company for O...
Read More >
The Southern District of New York granted a motion to compel arbitration of an employment dispute be...
Read More >
In response to the public-health crisis caused by the spread of COVID-19, Mayor Walsh has ordered al...
Read More >
Seyfarth Synopsis: The U.S. Bureau of Labor Statistics (BLS) recently released its annual National C...
Read More >
With the revised IR35 (off-payroll working) rules coming into force in the UK for private sector emp...
Read More >